Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses

Vaccine. 2015 Sep 22;33(39):5027-30. doi: 10.1016/j.vaccine.2015.08.021. Epub 2015 Aug 19.

Abstract

Several observational studies provide evidence that acellular pertussis vaccines (aP) are less protective against pertussis disease than highly effective whole-cell pertussis vaccines (wP), however, concerns have been raised that some of these findings may be confounded by age. By undertaking age-stratified and restricted analyses on a cohort of Australian children primed with either aP-only, wP-only or mixed pertussis vaccine schedules, we demonstrate that compared to aP the association of wP with increased protection from pertussis is not confounded by age, nor by aP booster-dose receipt.

Keywords: Acellular pertussis vaccine; Confounding; Pertussis; Vaccine effectiveness; Whole-cell pertussis vaccine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Australia
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Humans
  • Infant
  • Male
  • Pertussis Vaccine / administration & dosage*
  • Pertussis Vaccine / immunology*
  • Vaccines, Acellular / administration & dosage
  • Vaccines, Acellular / immunology
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / immunology
  • Whooping Cough / epidemiology*
  • Whooping Cough / prevention & control*

Substances

  • Pertussis Vaccine
  • Vaccines, Acellular
  • Vaccines, Inactivated